PBM executives are discussing ways to reduce prescription drug prices before Congress. Questions focus on pricing, rebates, and the intermediary role between pharmacies and drug manufacturers. Yahoo Finance's Anjalee Khemlani analyzes the testimonies and their impact on future operations.